EBITDA Margin (Quarterly)

EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues

Bio-Rad Laboratories, Inc. (BIO.B) EBITDA Margin data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$693.20M
Net Income	$720.00M
Cost of Goods Sold	$348.00M
Gross Profit	$345.20M
Operating Expenses	$812.10M
Operating Income	$-118.90M
Non-Operating Income/Expense	$1.05B
Pre-Tax Income	$929.20M
Normalized Pre-Tax Income	$-100.30M
Income after Taxes	$720.00M
Income from Continuous Operations	$720.00M
Consolidated Net Income/Loss	$720.00M
Normalized Income after Taxes	$-539.98M
EBIT	$-118.90M
EBITDA	$-118.90M
Weighted-Average Shares Outstanding (Basic)	27.26M
Weighted-Average Shares Outstanding (Diluted)	27.28M
Earnings per Share (EPS) (Basic)	$26.61
Earnings per Share (EPS) (Diluted)	$26.59
Balance Sheet Financials
Current Assets	$2.91B
Property, Plant, and Equipment	$539.90M
Long-Term Assets	$7.67B
Total Assets	$10.58B
Current Liabilities	$517.00M
Long-Term Debt	$1.20B
Long-Term Liabilities	$2.61B
Total Liabilities	$3.12B
Common Equity	$7.45B
Tangible Shareholders Equity	$6.70B
Shareholders Equity	$7.45B
Common Shares Outstanding	26.99M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$532.20M
Cash Flow from Investing Activities	$-189.70M
Cash Flow from Financial Activities	$-283.20M
Beginning Cash	$489.80M
End Cash	$532.20M
Increase/Decrease in Cash	$42.40M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.62
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.14
Debt to Equity Ratio	0.16
Gross Margin	49.80%
Operating Margin	-17.15%
EBIT Margin	-17.15%
EBITDA Margin	--
Pre-Tax Profit Margin	134.04%
Profit Margin	103.87%
Free Cash Flow	$374.70M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.07
Inventory Turnover	0.47
Receiveable Turnover	1.50
Days Sales in Receivables	59.80
Return on Equity	9.66%
Return on Tangible Equity	10.75%
Return on Assets	6.81%
Return on Investments	8.32%
Book Value Per Share	$276.16
Free Cash Flow per Share	$13.73
Operating Cash Flow per Share	$19.51

Data from Zacks Investment Research, Inc.